Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon

Infection, Genetics and Evolution

Volumn 8, Issue 5, 2008, Pages 676-681

  Pouillot, Régis ^a   Lachenal, Guillaume ^b   Pybus, Oliver G ^c   Rousset, Dominique ^a   Njouom, Richard ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b CNRS   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cameroon; HCV 2; Middle Africa; Population genetic history; West Africa

Indexed keywords

AFRICA; ARTICLE; BAYES THEOREM; CAMEROON; COMPARATIVE STUDY; CONTROLLED STUDY; EPIDEMIC; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENOTYPE; HEPATITIS C; HUMAN; LAST COMMON ANCESTOR; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POPULATION DIFFERENTIATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; VIRUS STRAIN;

AFRICA, WESTERN; BAYES THEOREM; CAMEROON; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHYLOGENY; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 2;

EID: 50249156825     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2008.06.001     Document Type: Article

References (46)

1. Bado, J.-P., 1996. Médecine coloniale et grandes endémies en Afrique, 1900-1960: lèpre, trypanosomiase humaine et onchocerchose. Paris, Karthala.
2. Candotti D., Temple J., Sarkodie F., and Allain J.-P. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J. Virol. 77 14 (2003) 7914-7923
3. Drummond A., Ho S.Y.W., Phillips M.J., and Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4 5 (2006)
4. Drummond A., and Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7 1 (2007) 214
5. Drummond, A.J., Ho, S.Y.W., Rawlence, N., Rambaut, A., 2007. A rough guide to BEAST 1.4, report. Auckland, New Zealand, 42 pp.
6. Drummond A.J., Rambaut A., Shapiro B., and Pybus O.G. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22 5 (2005) 1185-1192
7. Felsenstein J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17 (1981) 368-376
8. Felsenstein J., and Churchill G.A. A Hidden Markov model approach to variation among sites in rate of evolution. Mol. Biol. Evol. 13 (1996) 93-104
9. Frank C., Mohamed M., Strickland G., Lavanchy D., Arthur R., Magder L., El Khoby T., Abdel-Wahab Y., Aly Ohn E., Anwar W., and Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 9207 (2000) 887-891
10. Grischow, J.D., 2004. Tsetse and Trypanosomiasis in the Gold Coast, 1924-1954. WOPAG - Working Papers on Ghana: Historical and Contemporary Studies, Institute of Asian and African Studies, University of Helsinki, no. 5, pp. 1-22.
11. Grischow, J.D., 2006a. Globalisation, development and disease in colonial Northern Ghana, 1906-1960. WOPAG - Working Papers on Ghana: Historical and Contemporary Studies, Institute of Asian and African Studies, University of Helsinki, vol. 9, pp. 1-31.
12. Grischow J.D., and Morris K.R.S. Tsetse eradication in the Gold Coast, 1928-51. Africa 76 (2006) 381-401
13. Guindon S., and Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52 (2003) 696-704
14. Hasegawa M.H., Kishino H., and Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22 (1985) 160-174
15. Herbert E.W. Smallpox inoculation in Africa. J. African History 16 4 (1975) 539-559
16. Houillon D. Variole et vaccine en Afrique Occidentale Française pour l'année 1903. Annales d'Hygiène et de Médecine Coloniale 8 (1905) 546-568
17. Jeannel D., Fretz C., Traore Y., Kohdjo N., Bigot A., Pe Gamy E., Jourdan G., Kourouma K., Maertens G., Fumoux F., Fournel J., and Stuyver L. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J. Med. Virol. 55 2 (1998) 92-97
18. Jin L., and Nei M. Limitations of the evolutionary parsimony method of phylogenetic analysis. Mol. Biol. Evol. 7 (1990) 82-102
19. Juhé-Beaulaton D., and Lainé A. Processus d'acquisition et de transmission des ressources thérapeutiques africaines dans les sources européennes du XVIIe au XIXe siècle. Outre Mers 93 (2005) 47-78
20. Jukes T.H., and Cantor C.R. Evolution of protein molecules. In: Munro H.N. (Ed). Mammalian Protein Metabolism (1969), Academic Press, New York 21-132
21. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16 (1980) 111-120
22. Lanave C., Preparata G., Saccone C., and Serio G. A new method for calculating evolutionary substitutions rates. J. Mol. Evol. 20 1 (1984) 86-93
23. Madhava V., Burgess C., and Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect. Dis. 2 5 (2002) 293-302
24. McOmish F., Yap P., Dow B., Follett E., Seed C., Keller A., Cobain T., Krusius T., Kolho E., and Naukkarinen R. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32 4 (1994) 884-892
25. Nakano T., Lu L., Liu P., and Pybus O. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J. Infect. Dis. 190 6 (2004) 1098-1108
26. Ndjomou J., Pybus O.G., and Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J. Gen. Virol. 84 9 (2003) 2333-2341
27. Nerrienet E., Pouillot R., Lachenal G., Njouom R., Mfoupouendoun J., Bilong C., Pasquier C., and Ayouba A. Hepatitis C virus infection in Cameroon: a cohort-effect. J. Med. Virol. 76 (2005) 208-214
28. Njouom R., Nerrienet E., Dubois M., Lachenal G., Rousset D., Vessiere A., Ayouba A., Pasquier C., and Pouillot R. The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960. Infect. Genet. Evol. 7 (2007) 361-367
29. Njouom R., Pasquier C., Ayouba A., Gessain A., Froment A., Mfoupouendoun J., Pouillot R., Dubois M., Sandres-Saune K., Thonnon J., Izopet J., and Nerrienet E. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J. Med. Virol. 71 2 (2003) 219-225
30. Njouom R., Pasquier C., Ayouba A., Tejiokem M., Vessiere A., Mfoupouendoun J., Tene G., Eteki N., Monny lobe M., Izopet J., and Nerrienet E. Low risk of mother to child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am. J.Trop. Med. Hyg. 73 2 (2005) 460-466
31. Paradis E., Claude J., and Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20 (2004) 289-290
32. Pasquier C., Njouom R., Ayouba A., Dubois M., Sartre M.T., Vessiere A., Timba I., Thonnon J., Izopet J., and Nerrienet E. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J. Med. Virol. 77 3 (2005) 390-398
33. Patterson K.D. Health in colonial Ghana: disease, medicine, and socio-economic change 1900-1955 (1981), Crossroads Press, Waltham, Mass
34. Pepin J., and Labbe A.C. Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses. Trop. Med. Int. Health 13 6 (2008) 744-753
35. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., and Harvey P.H. The epidemic behavior of the hepatitis C virus. Science 292 5525 (2001) 2323-2325
36. Pybus O.G., Drummond A.J., Nakano T., Robertson B.H., and Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20 3 (2003) 381-387
37. Pybus O.G., Markov P.V., Wu A., and Tatem A.J. Investigating the endemic transmission of the hepatitis C virus. Int. J. Parasitol. 37 8-9 (2007) 839-849
38. Ruggieri A., Argentini C., Kouruma F., Chionne P., D'Ugo E., Spada E., Dettori S., Sabbatani S., and Rapicetta M. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J. Gen. Virol. 77 9 (1996) 2073-2076
39. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., Halfon P., Inchauspe G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin I.T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., and Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 4 (2005) 962-973
40. Tamura K., and Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10 (1993) 512-526
41. Tanaka Y., Agha S., Saudy N., Kurbanov F., Orito E., Kato T., Abo-Zeid M., Khalaf M., Miyakawa Y., and Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J. Mol. Evol. 58 2 (2004) 191-195
42. Tanaka Y., Hanada K., Mizokami M., Yeo A.E.T., Shih J.W.-K., Gojobori T., and Alter H.J. Inaugural Article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc. Natl. Acad. Sci. U.S.A. 99 24 (2002) 15584-15589
43. Thompson J., Gibson T., Plewniak F., Jeanmougin F., and Higgins D. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 24 (1997) 4876-4882
44. Verbeeck J., Maes P., Lemey P., Pybus O.G., Wollants E., Song E., Nevens F., Fevery J., Delport W., Van der Merwe S., and Van Ranst M. Investigating the origin and spread of hepatitis C virus genotype 5a. J. Virol. 80 9 (2006) 4220-4226
45. Wansbrough-Jones M., Frimpong E., Cant B., Harris K., Evans M., and Teo C. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans. R. Soc. Trop. Med. Hyg. 92 5 (1998) 496-499
46. WHO, 1999. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral. Hepat. 6 (1), 35-47.